Theranos was unable to find a buyer and aims to pay unsecured creditors its remaining cash of $5m, Wall Street Journal reports

The once-heralded blood-testing startup Theranos is shutting down, according to a media report.

Theranos was unable to sell itself and is now looking to pay unsecured creditors its remaining cash of about $5m in the upcoming months, according to an email the Wall Street Journal obtained that the CEO, David Taylor, sent to shareholders.

Continue reading…

Read More Once-heralded blood-testing startup Theranos is closing – report

Facebook Comments